OshudSodium Feredetate Trihydrate
Oral Iron preparations
Brands & Prices (3)
📋 Indications & Uses Dosage & Administration⚠️ Contraindications⚡ Side Effects & Adverse Reactions🛡️ Warnings & Precautions🔬 Pharmacology & Mechanism
Brand Formulations & Prices
3 brands sorted by unit price
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesFerokid syrup is an oral solution for adults, children and babies to treat iron deficiency anemia caused by too little iron in the body. The form of iron used in Ferokid means that it is less likely to cause stomach upsets than other iron-containing medicines, and will not
... Read more
Ferokid syrup is an oral solution for adults, children and babies to treat iron deficiency anemia caused by too little iron in the body. The form of iron used in Ferokid means that it is less likely to cause stomach upsets than other iron-containing medicines, and will not discolor teeth. It is indicated for:
Iron Deficiency Anemia (especially in children)
Pregnant women when other forms of oral iron may not be well tolerated
People who have become anemic as a result of having rheumatoid arthritis.
Dosage & AdministrationIron-deficiency anaemia (therapeutic): By mouth using oral solution
Neonate
: Up to 2.5 mL twice daily, smaller doses to be used initially.
Child 1-11 months
: Up to 2.5 mL twice daily, smaller doses to be used initially
Child 1-4 years
: 2.5 mL 3 times a day
Child 5-11 years
: 5 mL 3 times a day
Child 12-17 years
: 5 mL 3 times a day, increased to 10 mL 3 times a day, dose to be increased gradually
Iron-deficiency anaemia (prophylactic): By mouth using oral solution
Neonate
: 1 mL daily, prophylactic iron supplementation may be required in babies of low birth-weight who are solely breast-fed; supplementation is started 4-6 weeks after birth and continued until mixed feeding is established.
Child 1-11 months
: 1 mL daily, prophylactic iron supplementation may be required in babies of low birth-weight who are solely breast-fed; supplementation is started 4-6 weeks after birth and continued until mixed feeding is established.
Sodium Feredetate Trihydrate is contraindicated in patients with a history of:
Hypersensitivity to the active substance or to any of the excipients.
Haemochromatosis, haemosiderosis and other Iron overload syndromes.
Receiving repeated blood transfusions.
Allergic reactions: e.g. itchy skin rash, swelling of the face, lips, tongue or throat, or difficulty breathing or swallowing.
Care should be taken in patients with haemolytic anaemia, iron-storage or iron-absorption diseases or existing gastrointestinal diseases. Iron preparations color the faeces black, which may interfere with tests used for detection of occult blood in the stools. Prolonged or excessive use in children may lead to toxic accumulation.
Sodium Feredetate is not an iron salt as it contains iron in an un-ionised form. In this compound the iron is "insulated" or "sequestered" with the sodium salt of Ethylenediamine Tetra-Acetic Acid (EDTA) to form a chelate so it does not discolor teeth. The iron chelate is split within the gastro-intestinal tract and releases elemental iron.
Post-absorption distribution of elemental iron is as follows: 60% to 70% is incorporated into haemoglobin and most of the remainder is present in storage forms, either as ferritin or haemosiderin, in the reticulo-endothelial system and to a lesser extent, hepatocytes. A further 4% is present in myoglobin and haeme-containing enzymes, or bound to transferrin in plasma.
EDTA is poorly absorbed and passes through the body unchanged after reaching the bloodstream.